Generic Industry Consolidation Illustrated In ANDA Holder List
Executive Summary
Most of US FDA's approved ANDAs are owned by a handful of firms, while the vast majority of owners have between one and five.
You may also be interested in...
GDUFA II: More Than 2,000 ANDAs Remain Unclaimed, Large Firms Still Dominate
Firms could find themselves charged multiple US generic drug user fees if affiliates are not identified and ANDAs claimed.
GDUFA II: More Than 2,000 ANDAs Remain Unclaimed, Large Firms Still Dominate
Firms could find themselves charged multiple US generic drug user fees if affiliates are not identified and ANDAs claimed.
ANDA Holder Fee Will Start With Industry-Driven Database 'Clean-Up'
FDA is again relying on sponsor self-reporting as it launches GDUFA II.